Corvus Pharmaceuticals, Inc.
CRVS
$4.50
$0.000.00%
CRVS market cap represents
0.00%
of the sector.
Valuation
CRVS
Low
CRVS
Sector Average
High
Market Cap
289.16M
< 289.16M
> 16.04B
Enterprise Value
247.86M
< 240.00M
> 18.16B
Price/Earnings (TTM)
-4.86
< -10.00
> 10.00
Earnings Per Share Growth (TTM)
44.26%
< -50.00%
> 50.00%
Price/Earnings To Growth (TTM)
--
0.00
12.20
Price/Sales (TTM)
--
-18,900.00
26,000.00
Price/Book (Q)
22.69
< 0.00
> 30.00
Enterprise Value/Revenue (TTM)
--
-8,502.33
13,513.05
Enterprise Value/EBITDA (TTM)
-9.92
< -10.00
> 0.00
Enterprise Value/EBIT (TTM)
-9.89
< -10.00
> 10.00
Dividends and Shares
CRVS
Low
CRVS
Sector Average
High
Shares Outstanding
66.70M
< 60.00M
> 250.00M
Dividend Per Share (Most Recent)
--
0.00
2.38
Dividend Per Share (TTM)
--
0.00
9.13
Dividend Yield (TTM)
--
0.00%
7.71%
Payout Ratio (TTM)
--
-1,820.24
926.87
Price History
CRVS
Low
CRVS
Sector Average
High
Beta
2.34
< -10.00
5.83
1-Month Total Return
-7.79%
< -30.00%
> 0.00%
3-Month Total Return
-34.78%
< -40.00%
> 0.00%
6-Month Total Return
-22.15%
< -30.00%
> 10.00%
Year to Date Total Return
-17.13%
< -20.00%
> 0.00%
1-Year Total Return
139.36%
< 0.00%
> 140.00%
2-Year Total Return
559.73%
< 100.00%
> 560.00%
3-Year Total Return
200.00%
< -10.00%
> 200.00%
5-Year Total Return
158.62%
< 50.00%
> 210.00%
Profitability
CRVS
Low
CRVS
Sector Average
High
Operating Margin (TTM)
--
-515,860.00%
1,222,368.18%
Profit Margin (TTM)
--
-475,295.00%
1,304,127.27%
Management Effectiveness
CRVS
Low
CRVS
Sector Average
High
Return on Assets (TTM)
-28.30%
< -50.00%
> -10.00%
Return on Equity (TTM)
--
0.26%
824.40%
Income Statement
CRVS
Low
CRVS
Sector Average
High
Revenue (TTM)
--
-4.27M
370.66B
Total Revenue (TTM)
--
-4.27M
400.28B
Total Revenue Growth (Q YOY)
--
-100.61%
206,582.61%
Revenue Per Share (TTM)
--
-8.53
37,070.00
Gross Profit (TTM)
--
-2.77B
89.40B
EBITDA (TTM)
-24.98M
< -30.00M
> 1.10B
EBIT (TTM)
-25.07M
< -30.00M
> 730.00M
Net Income (TTM)
-56.83M
< -60.00M
> 270.00M
Net Income Avl. to Common (TTM)
-56.83M
< -60.00M
> 270.00M
Earnings Growth (Q YOY)
-570.28%
< -580.00%
> -60.00%
EPS Diluted (TTM)
-0.93
< -5,460.00
> 0.00
EPS Diluted Growth (Q YOY)
-392.16%
< -400.00%
> 0.00%
Balance Sheet
CRVS
Low
CRVS
Sector Average
High
Cash and Short-Term Inv. (Q)
41.65M
< 40.00M
> 1.37B
Cash Per Share (Q)
0.62
0.00
> 200.00
Total Current Assets (Q)
42.92M
< 40.00M
> 3.45B
Total Assets (Q)
58.82M
< 50.00M
> 9.77B
Total Current Liabilities (Q)
46.41M
< 40.00M
> 2.57B
Total Debt (Q)
354.00K
0.00
> 3.14B
Total Liabilities (Q)
46.41M
< 40.00M
> 6.13B
Total Common Equity (Q)
12.41M
< 10.00M
> 3.54B
Total Preferred Equity (Q)
--
0.00
920.42M
Total Equity (Q)
12.41M
< 10.00M
> 3.64B
Current Ratio (Q)
0.925
0.009
> 20.000
Book Value Per Share (Q)
0.20
< 0.00
> 2,160.00
Cash Flow
CRVS
Low
CRVS
Sector Average
High
Cash from Operations (TTM)
-22.13M
< -30.00M
> 720.00M
Cash from Investing (TTM)
-23.72M
< -590.00M
> -20.00M
Cash from Financing (TTM)
30.42M
< -190.00M
> 40.00M
Net Change in Cash (TTM)
-15.42M
< -40.00M
> 0.00
Levered Free Cash Flow (TTM)
26.93M
< 20.00M
> 540.00M
The comparison requires a security to have a minimum 30 day average trading volume of 100,000 at $1 or over, or a $5 minimum price.
* Lowest and highest value for any one individual security in the sector.
